CDKN2B and ductal breast carcinoma in situ: We identified a gene that guards cell cycle progression, CDKN2B, to be hypermethylated and likely silenced in TN-DCIS and invasive stages of TNBC, potentially supporting uncontrolled cell proliferation characteristic of later stages of TN-DCIS progression.